Preparation of bismuth modified electrodes for the CO2 reduction reaction

In this work, several Bismuth electrodes were produced for the electrochemical reduction of CO2. Systematic studies were performed to investigate how modification of the surface of the electrodes would influence the catalytic activity of the system. The modifications were performed, by first, performing several electrodepositions, in order to obtain electrodeposits with different characteristics (Bi modified electrodes); and second, using co-catalysts (ionic liquids, ILs). During the electrodepositions, the morphology and distribution of the particles were investigated as a function of the deposition parameters with a view to optimising the bismuth surface coverage, the electrocatalytic properties and the meso to nano porosity so as to enhance mass transport. By controlling the waveform and additives within the deposition solution, several types of bismuth micro- to nano-structures could be produced ranging from fractals to approximately spherical particles. Bulk Bi electrodes were also produced so that a standard Bi electrode was set for comparison purposes. Finally, the Bi electrodes were then tested for the reduction of CO2 in aqueous solution in the absence and presence of commercial (1-Butyl-3-methylimidazolium tetrafluoroborate) and modified (1-carboxypropyl-3-methylimidazole tetrafluoroborate) ILs. The systems investigated within this work did not show high selectivity toward CO2 reduction and the main process at the electrode surface was the production of H2. The different parameters influenced the selectivity and the catalytic currents marginally. In addition, the modified Bi electrodes did not show a good stability during catalysis. For this reason, to try and increase the stability of the Bi catalysts, screen printed Bi electrodes were produced. The electrodes were produced first by preparing inks using Bi metal particles and then printing them on inert substrates. The obtained electrodes were characterised and finally tested via preliminary cyclic voltammetry experiments. This approach allowed more robust electrodes and higher reproducibility

Genetic diversity of Sardinian goat population based on microsatellites

During the last century, the selection for production traits of the main livestock species has led to a reduction in number of local populations with consequent loss of genetic variability. In Sardinia, the genetic improvement strategy has been based on selection for the local pure breed in sheep, whereas in the other species (cattle, swine and goat), an often unplanned crossbreeding with improved breeds has been applied. In this context, several studies on genetic diversity of these populations have been started with the final aim of recovering the autochthonous genetic types. The global approach involves different steps: - characterization of the farming system and typical products; - morphological and productive evaluation of the animals; - genetic characterization of the populations through molecular DNA analyses (microsatellites, AFLP, mitochondrial DNA, etc.); - creation of nucleus flocks in public farms and germoplasm banks; - organization of herd-books involving farmers interested in the safeguard of local breeds and valorisation of traditional products. A far as the goat population is concerned, Sardinia is the Italian region with the largest goat stock, (209.000 heads, about 23% of the total national stock). Farms are located in mountains, low hills and even plans (Macciotta et al., 2002) resulting in a quite large variability (Brandano and Piras, 1978) in terms of feeding and management techniques; but extensive and semi extensive systems in marginal areas prevail (Carta et al., 2001; Usai et al., 2004). The current population has been constituted by crossbreeding the autochthonous animals with other improved Mediterranean breeds,mainly Maltese goat. The aim of this paper is to study the genetic variability of this population through the analysis of 17 microsatellite markers

Interaction between <i>Mycobacterium tuberculosis</i>, <i>Mycobacterium bovis</i>, <i>Mycobacterium avium</i> subspecies <i>paratuberculosis</i> with the enteric glia and microglial cells

Background We investigated the interaction of Mycobacterium avium subspecies paratuberculosis, M. bovis and M. tuberculosis and different glial cells (enteric glial and microglial cells) in order to evaluate the infecting ability of these microorganisms and the effects produced on these cells, such as the evaluation of cytokines expression. Results Our experiments demonstrated the adhesion of M. paratuberculosis to the enteroglial cells and the induction of IL-1A and IL-6 expression; M. tuberculosis and M. bovis showed a good adhesive capability to the enteric cell line with the expression of the following cytokines: IL-1A and IL-1B, TNF-α, G-CSF and GM-CSF; M. bovis induced the expression of IL-6 too. The experiment performed with the microglial cells confirmed the results obtained with the enteroglial cells after the infection with M. tuberculosis and M. bovis, whereas M. paratuberculosis stimulated the production of IL-1A and IL-1B. Conclusion Enteroglial and microglial cells, could be the target of pathogenic mycobacteria and, even if present in different locations (Enteric Nervous System and Central Nervous System), show to have similar mechanism of immunomodulation

Facile assembly of polyoxometalate-polyelectrolyte films on nano-MO2 (M = Sn, Ti) for optical applications

The polyoxometalate [PMo12O40] 3- (POM) has been deposited onto high surface area nano-SnO2 using a polycation. The POM surface coverage recorded was approximately 17 times higher than that achieved on planar substrates using the same method, reducing considerably the time needed to assemble conducting films suitable for optical applications such as electrochromism. The immobilisation of the analogous tungstate [PW12O40] 3- onto a nano-TiO2 semiconductor electrode demonstrates the versatility of this approach, and underscores potential applications using a large combination of polyoxomolybdates or polyoxotungstates with various metal oxide films

Thoracic Duct Embolization for Delayed Chyle Leak After Lewis-Tanner Esophagectomy

BACKGROUND Radical esophagectomy for cancer is a potentially curative treatment that requires two/three-field lymphadenectomy. Serious complications can occur, including chyle leak (CL). CL has an incidence rate of 1-9% and is associated with a higher rate of postsurgical morbidity and mortality. It usually occurs in the early postoperative period; delayed CL is less common and is thought to be due to an occult leak or late diagnosis. CASE REPORT A 54-year-old man with adenocarcinoma of the esophagus underwent Lewis-Tanner esophagectomy after neoadjuvant chemotherapy with FLOT. During en bloc lymphadenectomy, the main thoracic duct was identified, clipped, and divided. The postoperative course was uneventful. One month after hospital discharge, he was readmitted with severe abdominal, scrotal, and lower-limb edema. A chest-abdomen CT scan revealed massive pleural effusion with left shift and compression of the mediastinum. The patient was initially treated with fasting and fat-free total parenteral nutrition, and the drain output was 2800-3000 mL/dL. Lymphoscintigraphy with ethiodized oil eventually revealed a thoracic duct leak, and lymphatic embolization was successfully performed with a 4-mm metallic spiral and glue. Drain output dramatically reduced, and after 11 days the thoracic drain was removed and the patient was safely discharged. CONCLUSIONS Thoracic duct embolization seems be an effective therapy in treating high-output (&gt;1000 mL/dL) CL that has occurred more than 2 weeks after esophagectomy. It can be considered as a first-line treatment due to its simplicity and effectiveness

Interaction between Mycobacterium tuberculosis, Mycobacterium bovis, Mycobacterium avium subspecies paratuberculosis with the enteric glia and microglial cells

<p>Abstract</p> <p>Background</p> <p>We investigated the interaction of <it>Mycobacterium avium </it>subspecies <it>paratuberculosis, M. bovis </it>and <it>M. tuberculosis </it>and different glial cells (enteric glial and microglial cells) in order to evaluate the infecting ability of these microorganisms and the effects produced on these cells, such as the evaluation of cytokines expression.</p> <p>Results</p> <p>Our experiments demonstrated the adhesion of <it>M. paratuberculosis </it>to the enteroglial cells and the induction of IL-1A and IL-6 expression; <it>M. tuberculosis </it>and <it>M. bovis </it>showed a good adhesive capability to the enteric cell line with the expression of the following cytokines: IL-1A and IL-1B, TNF-α, G-CSF and GM-CSF; <it>M. bovis </it>induced the expression of IL-6 too.</p> <p>The experiment performed with the microglial cells confirmed the results obtained with the enteroglial cells after the infection with <it>M. tuberculosis </it>and <it>M. bovis</it>, whereas <it>M. paratuberculosis </it>stimulated the production of IL-1A and IL-1B.</p> <p>Conclusion</p> <p>Enteroglial and microglial cells, could be the target of pathogenic mycobacteria and, even if present in different locations (Enteric Nervous System and Central Nervous System), show to have similar mechanism of immunomodulation.</p

Open Surgery for Sportsman's Hernia a Retrospective Study

Sportsman's hernia is a painful syndrome in the inguinal area occurring in patients who play sports at an amatorial or professional level. Pain arises during sport, and sometimes persists after activity, representing an obstacle to sport resumption. A laparoscopic/endoscopic approach is proposed by many authors for treatment of the inguinal wall defect. Aim of this study is to assess the open technique in terms of safety and effectiveness, in order to obtain the benefit of an open treatment in an outpatient management. From October 2017 to July 2019, 34 patients underwent surgery for groin pain syndrome. All cases exhibited a bulging of the inguinal posterior wall. 14 patients were treated with Lichtenstein technique with transversalis fascia plication and placement of a polypropylene mesh fixed with fibrin glue. In 20 cases, a polypropylene mesh was placed in the preperitoneal space. The procedure was performed in day surgery facilities. Early or late postoperative complications did not occur in both groups. All patients returned to sport, in 32 cases with complete pain relief, whereas 2 patients experienced mild residual pain. The average value of return to sport was 34.11 ± 8.44 days. The average value of return to play was 53.82 ± 11.69 days. With regard to postoperative pain, no substantial differences between the two techniques were detected, and good results in terms of the resumption of sport were ensured in both groups. Surgical treatment for sportsman's hernia should be considered only after the failure of conservative treatment. The open technique is safe and allows a rapid postoperative recovery

Hematopietic Stem Cell Transplantation in Thalassemia and Related Disorders

The basis of allogeneic hemopoietic stem cell (HSC) transplantation in thalassemia consists in substituting the ineffective thalassemic erythropoiesis with and allogeneic effective one. This cellular replacement therapy is an efficient way to obtain a long lasting, probably permanent, clinical effective correction of the anaemia avoiding transfusion requirement and subsequent complications like iron overload. The first HSC transplant for thalassemia was performed in Seattle on Dec 2, 1981. In the early eighties transplantation procedure was limited to very few centres worldwide. Between 17 December 1981 and 31 January 2003, over 1000 consecutive patients, aged from 1 to 35 years, underwent transplantation in Pesaro. After the pioneering work by the Seattle and Pesaro groups, this therapeutic approach is now widely applied worldwide. Medical therapy of thalassemia is one of the most spectacular successes of the medical practice in the last decades. In recent years advances in knowledge of iron overload patho-physiopathology, improvement and diffusion of diagnostic capability together with the development of new effective and safe oral chelators promise to further increase success of medical therapy. Nevertheless situation is dramatically different in non-industrialized countries were the very large majority of patients live today. Transplantation technologies have improved substantially during the last years and transplantation outcome is likely to be much better today than in the ‘80s. Recent data indicated a probability of overall survival and thalassemia free survival of 97% and 89% for patients with no advanced disease and of 87% and 80% for patients with advanced disease. Thus the central role of HSC in thalassemia has now been fully established. HSC remains the only definitive curative therapy for thalassemia and other hemoblobinopathies. The development of oral chelators has not changed this position. However this has not settled the controversy on how this curative but potentially lethal treatment stands in front of medical therapy for adults and advanced disease patients. In sickle cell disease HSC transplantation currently is reserved almost exclusively for patients with clinical features that indicate a poor outcome or significant sickle-related morbidity